XML 25 R14.htm IDEA: XBRL DOCUMENT
v3.20.2

Capital Stock and Earnings (Loss) Per Share | 9 Months Ended
--- | ---
Oct. 31, 2020
Equity [Abstract] |
Capital Stock and Earnings (Loss) Per Share | Capital Stock and Earnings (Loss) Per Share Capital Stock In March 2020, in connection with the actions taken related to the COVID-19 pandemic as described in Note B—Impact of the COVID-19 Pandemic, the Company suspended its share repurchase program. During the first quarter of fiscal 2021, prior to the suspension of our share repurchase program, TJX repurchased and retired 3.2 million shares of its common stock at a cost of $190.1 million on a “trade date” basis. All share repurchases occurred during the first quarter of fiscal 2021. TJX reflects stock repurchases in its financial statements on a “settlement date” or cash basis. TJX had cash expenditures under repurchase programs of $201.5 million for the nine months ended October 31, 2020 and $1.2 billion for the nine months ended November 2, 2019. These expenditures were funded by cash generated from operations. In February 2020, the Company announced that its Board of Directors had approved in January 2020 a new stock repurchase program that authorizes the repurchase of up to an additional $1.5 billion of TJX common stock from time to time. In February 2019, TJX announced that its Board of Directors had approved an additional stock repurchase program that authorized the repurchase of up to $1.5 billion of TJX common stock from time to time. As of October 31, 2020, TJX had approximately $3.0 billion available under these previously announced stock repurchase programs. All shares repurchased under the stock repurchase programs have been retired. Earnings (Loss) Per Share The following table presents the calculation of basic and diluted earnings (loss) per share for net income (loss):
| Thirteen Weeks Ended | Thirty-Nine Weeks Ended
Amounts in thousands, expect per share amounts | October 31, 2020 | November 2, 2019 | October 31, 2020 | November 2, 2019
Basic earnings (loss) per share: |  |  |  |
Net income (loss) | $ | 866,656 |  | $ | 828,263 |  | $ | (235,053) |  | $ | 2,287,403 |
Weighted average common shares outstanding for basic earnings (loss) per share calculation | 1,199,951 |  | 1,206,369 |  | 1,198,798 |  | 1,210,475 |
Basic earnings (loss) per share | $ | 0.72 |  | $ | 0.69 |  | $ | (0.20) |  | $ | 1.89 |
Diluted earnings (loss) per share: |  |  |  |
Net income (loss) | $ | 866,656 |  | $ | 828,263 |  | $ | (235,053) |  | $ | 2,287,403 |
Weighted average common shares outstanding for basic earnings (loss) per share calculations | 1,199,951 |  | 1,206,369 |  | 1,198,798 |  | 1,210,475 |
Assumed exercise / vesting of: |  |  |  |
Stock options and awards | 14,244 |  | 17,919 |  | — |  | 18,428 |
Weighted average common shares outstanding for diluted earnings (loss) per share calculation | 1,214,195 |  | 1,224,288 |  | 1,198,798 |  | 1,228,903 |
Diluted earnings (loss) per share | $ | 0.71 |  | $ | 0.68 |  | $ | (0.20) |  | $ | 1.86 |
Cash dividends declared per share | $ | — |  | $ | 0.230 |  | $ | — |  | $ | 0.690 |
The weighted average common shares for the diluted earnings per share calculation excludes the impact of outstanding stock options if the assumed proceeds per share of the option is in excess of the average price of TJX’s common stock for the related fiscal period. Such options are excluded because they would have an antidilutive effect. There were 17.7 million such options excluded for the thirteen weeks ended October 31, 2020. There were 12.0 million such options excluded for each of the thirteen weeks and thirty-nine weeks ended November 2, 2019. During periods of net loss, all common stock equivalents are excluded because they are anti-dilutive. For the thirty-nine weeks ended October 31, 2020, there were approximately 49.1 million common stock equivalents excluded from diluted earnings per share. In November 2020, the Company announced that it expects a quarterly dividend of $0.26 per share to be declared in the fourth quarter of fiscal 2021, payable in March 2021, subject to approval by its Board of Directors.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration